Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | GNAS complex locus | Starlite/ChEMBL | No references |
Homo sapiens | ATPase family, AAA domain containing 5 | Starlite/ChEMBL | No references |
Homo sapiens | glycoprotein hormones, alpha polypeptide | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Toxoplasma gondii | intraflagellar transport protein 172, putative | glycoprotein hormones, alpha polypeptide | 116 aa | 94 aa | 26.6 % |
Schistosoma mansoni | GTP-binding protein alpha subunit gna | GNAS complex locus | 394 aa | 450 aa | 28.7 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | bile acid beta-glucosidase-related | 0.2992 | 0.7365 | 0.7373 |
Echinococcus granulosus | non lysosomal glucosylceramidase | 0.2992 | 0.7365 | 0.7373 |
Echinococcus multilocularis | lysosomal alpha glucosidase | 0.1766 | 0.2878 | 0.321 |
Echinococcus granulosus | bile acid beta glucosidase | 0.2992 | 0.7365 | 0.7373 |
Echinococcus multilocularis | non lysosomal glucosylceramidase | 0.2992 | 0.7365 | 0.8216 |
Loa Loa (eye worm) | ceramide glucosyltransferase | 0.3429 | 0.8963 | 0.8544 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.2567 | 0.5809 | 0.1027 |
Echinococcus granulosus | ceramide glucosyltransferase | 0.3429 | 0.8963 | 1 |
Onchocerca volvulus | Glucosylceramidase homolog | 0.2436 | 0.5329 | 0.5571 |
Schistosoma mansoni | bile acid beta-glucosidase-related | 0.2992 | 0.7365 | 0.7373 |
Brugia malayi | Ceramide glucosyltransferase | 0.3429 | 0.8963 | 0.8544 |
Echinococcus multilocularis | lysosomal alpha glucosidase | 0.1766 | 0.2878 | 0.321 |
Schistosoma mansoni | ceramide glucosyltransferase | 0.3429 | 0.8963 | 1 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.2567 | 0.5809 | 0.1027 |
Echinococcus multilocularis | ceramide glucosyltransferase | 0.3429 | 0.8963 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.202 | 0.3807 | 0.1305 |
Schistosoma mansoni | ceramide glucosyltransferase | 0.3429 | 0.8963 | 1 |
Onchocerca volvulus | Ceramide glucosyltransferase homolog | 0.3429 | 0.8963 | 1 |
Echinococcus multilocularis | bile acid beta glucosidase | 0.2992 | 0.7365 | 0.8216 |
Giardia lamblia | Ceramide glucosyltransferase | 0.1555 | 0.2105 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 1.5849 uM | PubChem BioAssay. qHTS for Activators of Integrin-Mediated Alleviation for Muscular Dystrophy. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 11.2202 uM | PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 16.3535 uM | PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125] | ChEMBL. | No reference |
Potency (functional) | = 39.8107 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: Inhibitors of the vitamin D receptor (VDR): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504855] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.